Publications by authors named "Brielle Demuth"
Article Synopsis
- A study investigated whether a daily aspirin dose of 75 to 81 mg, started during the first trimester of pregnancy, could prevent preterm pre-eclampsia, building on previous findings that 150 mg daily is effective.
- Researchers conducted a systematic review of 11 randomized controlled trials involving nearly 14,000 participants, assessing the effectiveness of lower aspirin doses compared to placebo.
- The analysis found no significant reduction in preterm pre-eclampsia with the lower doses, but the variability among the studies was high, making it unclear if those doses could effectively influence pregnancy outcomes.
Impact of COVID-19 and Vaccination During Pregnancy on Placenta-Mediated Complications (COVIGRO Study).
J Obstet Gynaecol Can
April 2024
Objectives: COVID-19 has been associated with preterm birth (PTB) and placental-mediated complications, including fetal growth restriction and preeclampsia (PE). This study aimed to estimate the impact of COVID-19 and vaccination on adverse pregnancy outcomes and markers of placental function.
Methods: We performed a study on a prospective cohort of women recruited in the first trimester of pregnancy during the early COVID-19 pandemic period (December 2020 to December 2021).
Reply: Current optimal dose of aspirin for the prevention of preterm preeclampsia.
Am J Obstet Gynecol MFM
October 2023
Optimal dose of aspirin for the prevention of preterm preeclampsia.
Am J Obstet Gynecol
November 2023